Buzzberg Cup Live

u/Qwerty_gu

Reddit r/ValueInvesting
· tracked since Mar 2026
Calls
1
Win Rate
100.0%
return
+32.5%
Calls 1 1 Posts tracked · 0.0/day
Calls
7d 0
30d 0
90d 0
Best Calls
NVO long +32.5%
Worst Calls
No live losers yet
Most Mentioned
NVO ×1
Recent Calls
NVO long 3 months ago
Win Rate 100% Long 1 Short 0
Win Rate
7d 0%
30d 100%
90d 100%
Average Return +32.5% Long Return +32.5% Short Return -
Average Return
7d -3.0%
30d +3.6%
90d +15.7%
Result
Result
Sort
Theme Stance
Ticker
Side
Mentions
Opened
Entry
P&L
Thesis
Theme
Source
NVO Novo Nordisk A/S Novo Nordisk A/S
Long
Mar 15
$37.96
+32.5%
The market for obesity treatments and GLP-1 therapies is large and growing, with structural long-term demand. The current market price of Novo Nordisk (EUR 33.1) does not fully reflect this long-term growth potential, leading to an undervaluation compared to the author's calculated fair value (EUR 47.7). Novo Nordisk is undervalued because the market underestimates the size and durability of the obesity drug market, presenting a long-term buying opportunity. Increased competition, pricing pressure from payers, unexpected side effects from GLP-1 drugs, or a slowdown in market adoption could invalidate the thesis.
The market for obesity treatments and GLP-1 therapies is large and growing, with structural long-term demand. The current market price of Novo Nordisk (EUR 33.1) does not fully reflect this long-term growth potential, leading to an undervaluation compared to the author's calculated fair value (EUR 47.7). Novo Nordisk is undervalued because the market underestimates the size and durability of the obesity drug market, presenting a long-term buying opportunity. Increased competition, pricing pressure from payers, unexpected side effects from GLP-1 drugs, or a slowdown in market adoption could invalidate the thesis.
Healthcare
REDDIT
Showing 1 of 1 picks · sorted by mentions

u/Qwerty_gu has 1 trade ideas tracked on Buzzberg across 1 tickers since March 2026. Most covered: NVO.